What question did this study set out to answer?

To evaluate the incidence, risk factors, and outcomes of secondary malignancies in HCT recipients.

May 13, 2026

Secondary Malignancies after Hematopoietic Stem Cell Transplantation.

View Full Paper

Ask AI

Bookmark

Authors

PCPedro Asensi CantóHospital Universitari i Politècnic La Fe MMMiguel Mansilla-PoloHospital Universitari i Politècnic La Fe JMJuan MontoroHospital Universitari i Politècnic La Fe

Discussion

Member takes

Implication

Observational study shows risk factors for secondary malignancies in long-term survivors of hematopoietic stem cell transplantation, implying the need for careful monitoring.

Key Points

To evaluate the incidence, risk factors, and outcomes of secondary malignancies in HCT recipients.
Observational, retrospective, single-center study design
Included 2,098 patients undergoing first autologous or allogeneic HCT
Conducted at Hospital Universitario y Politécnico La Fe in Valencia, Spain
Analyzed incidence and outcomes of non-cutaneous secondary malignancies
4.9% of patients developed non-cutaneous secondary malignancies
Solid tumors, PTLD, t-MDS/AML were major types observed
PTLD occurred earlier post-transplant compared to other malignancies
Risk factors included prior malignancy, allogeneic HCT, and older age

Cite This Study

Cantó et al. (2026) studied this question.

synapsesocial.com/papers/6a03cbe01c527af8f1ecfa12 https://doi.org/10.1016/j.jtct.2026.04.025

View Full Paper

Ask AI

Bookmark

Implication

Observational study shows risk factors for secondary malignancies in long-term survivors of hematopoietic stem cell transplantation, implying the need for careful monitoring.

Secondary Malignancies after Hematopoietic Stem Cell Transplantation.

Discussion

Member takes

Implication

Key Points

Cite This Study

Secondary Malignancies after Hematopoietic Stem Cell Transplantation.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider